Kabra Drugs Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|
Revenue | TBA | TBA | TBA |
Operating Expense | 0.40 | 0.55 | 0.37 |
Net Profit | -0.40 | -0.55 | -0.37 |
Net Profit Margin | TBA | TBA | TBA |
Earning Per Share | -0.39 | -1.24 | -0.84 |
EBIDTA | -0.40 | -0.55 | -0.37 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Sep 2024 |
---|---|
Revenue | TBA |
Operating Expense | 0.40 |
Net Profit | -0.40 |
Net Profit Margin | TBA |
Earning Per Share | -0.39 |
EBIDTA | -0.40 |
Effective Tax Rate | TBA |
Invest in Kabra Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | TBA | TBA | TBA |
Operating Expenses Annual | 0.74 | 0.34 | 0.18 |
Operating Profit Annual | -0.74 | -0.34 | -0.18 |
Interest Annual | TBA | TBA | TBA |
Depreciation | TBA | TBA | 0.01 |
Net Profit Annual | -0.74 | -0.34 | -0.19 |
Tax Annual | TBA | TBA | TBA |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | TBA |
Operating Expenses Annual | 0.74 |
Operating Profit Annual | -0.74 |
Interest Annual | TBA |
Depreciation | TBA |
Net Profit Annual | -0.74 |
Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | TBA | TBA | 0.01 |
Cash Flow from Operations | -0.21 | -0.35 | -0.13 |
Cash Flow from Investing | TBA | TBA | TBA |
Cash Flow from Financing | 2.88 | 0.36 | 0.13 |
Cash Flow at the End | 2.67 | TBA | TBA |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | TBA |
Cash Flow from Operations | -0.21 |
Cash Flow from Investing | TBA |
Cash Flow from Financing | 2.88 |
Cash Flow at the End | 2.67 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | TBA | TBA | TBA |
PBIT Margin (%) | TBA | TBA | TBA |
PBT Margin (%) | TBA | TBA | TBA |
Net PROFIT Margin (%) | TBA | TBA | TBA |
Return On Networth / Equity (%) | TBA | TBA | TBA |
Return On Networth /Employed (%) | TBA | TBA | TBA |
Return On Assets (%) | TBA | TBA | TBA |
Total Debt / Equity (X) | 8.83 | TBA | TBA |
Asset Turnover Ratio (%) | TBA | TBA | TBA |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | TBA |
PBIT Margin (%) | TBA |
PBT Margin (%) | TBA |
Net PROFIT Margin (%) | TBA |
Return On Networth / Equity (%) | TBA |
Return On Networth /Employed (%) | TBA |
Return On Assets (%) | TBA |
Total Debt / Equity (X) | 8.83 |
Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | TBA | TBA | TBA |
Total Current Assets Annual | 4.55 | 0.68 | 0.71 |
Non Current Assets Annual | 0.02 | 0.02 | 0.02 |
Total Shareholders Funds Annual | 1.08 | -0.73 | -0.39 |
Total Assets Annual | 4.57 | 0.70 | 0.73 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | TBA |
Total Current Assets Annual | 4.55 |
Non Current Assets Annual | 0.02 |
Total Shareholders Funds Annual | 1.08 |
Total Assets Annual | 4.57 |
No Data Availabe